Background. Injury to the thoracic duct (TD) is the most common complication after a left lateral neck dissection, and it carries a high degree of morbidity. Currently, no routine diagnostic imaging is used to assist with TD identification intraoperatively. This report describes the first clinical experience with lymphangiography using indocyanine green (ICG) during lateral neck dissections. Methods. In six patients undergoing left lateral neck dissection (levels 2-4) for either thyroid cancer or melanoma, 2.5-5 mg of ICG was injected in the dorsum of the left foot 15 min before imaging. Intraoperative imaging was performed with a hand-held near infrared (NIR) camera (Hamamatsu, PDE-Neo, Hamamatsu City, Japan). Results. In five patients, the TD was visualized using NIR fluorescence, with a time of 15-90 min from injection to identification. Imaging was optimized by positioning the camera at the angle of the mandible and pointing into the space below the clavicle. No adverse reactions from the ICG injection occurred, and the time required for imaging was 5-10 min. No intraoperative TD injury was identified, and no chyle leak occurred postoperatively. For the one patient in whom the TD was not identified, it is unclear whether this was related to the timing of the injection or to duct obliteration from a prior dissection. Conclusion. This is the first described application of ICG lymphangiography to identify the thoracic duct during left lateral neck dissection. Identification of TD with ICG is technically feasible, simple to perform with NIR imaging, and safe, making it a potential important adjunct for the surgeon.
1
Injury occurs when insertion of the thoracic duct (TD) or a branch of it is disrupted from the junction of the internal jugular and subclavian vein.
The TD is a 3-5-mm lymphatic channel, which normally returns 2-4 L of triglyceride-rich chyle from the thoracic and abdominal compartment to the central venous circulation. The cervical course of the TD varies significantly, but the majority of cadaveric studies have found a single duct and single termination. 2 The right-sided lymphatic duct drains chyle from the head, thorax, and right arm into the right subclavian vein.
Up to 25% of all TD injuries causing fistula occur in the right neck. Thyroidectomy involving a central neck dissection has a low rate of injury and fistula (1.4%). 3 Injury also has been reported after penetration of neck trauma or cervical rib resection for thoracic outlet obstruction, typically causing chylothorax. 4 Injury to the TD occurs during neck dissection (modified radical or selective) around the confluence of the internal jugular and subclavian vein (level 4) in the lower neck. Preservation does not always occur because identification can be difficult due to the duct's small and paper-thin appearance as well as its variable anatomic course. Its location and appearance also may be altered by pathologic lymphadenopathy. Injury is frequently technical in nature, although patient-specific factors that make it difficult to visualize structures properly, such as a scarring from a prior surgery or radiation or a short obese neck, may have an impact on injury rates. Its fragile nature also contributes to its high inadvertent injury rate. A leak of typically clear chylous fluid can be difficult to detect intraoperatively, making identification and repair problematic. Finally, the fragile composition of the wall of the TD often makes repair challenging even when injury is identified.
The morbidity rate associated with chyle leak can be quite high, including wound complications and progression of fluid drainage into the mediastinum and chest, resulting in chylothorax. Standard management initially consists of conservative measures, including a no-fat diet or a diet with only medium-chain fatty acids, and the use of octreotide. 5, 6 If the fistula persists, then nothing by mouth and intravenous nutrition can sometimes achieve spontaneous closure within 1 week. 7 A high-output chylous leak lasting longer than 5-7 days can cause severe nutritional and immunologic depletion, and surgical repair is recommended. 2 Currently, a variety of minimally invasive lymphangiography-guided procedures can be first attempted instead of open repair, including ligation of the TD in the chest. 8 Strategies to recognize and prevent injury to the TD intraoperatively are not commonly used and are reported sparsely in the literature. Indocyanine green (ICG) is a fluorescent dye that binds to intravascular and intra-lymphatic proteins, and its fluorescent properties make these vessels visible with near-infrared (NIR) light. 9 Clinical use of ICG, dating back to the 1960s, is frequently used in surgery for a variety of purposes including sentinel lymph node identification in gynecologic and head and neck cancers, evaluation of anastomotic perfusion in colorectal surgery, fluorescent-guided resection of liver tumors, and lymphatic mapping during surgical correction of lymphedema. [10] [11] [12] [13] [14] Case reports show ICG used successfully to identify the TD in the abdomen and chest to allow for ligation in the treatment of postoperative chylothorax and chylous ascites. [15] [16] [17] This report presents the first use of a technique to identify and preserve the TD during lateral neck dissection using ICG lymphangiography. We have determined that identification of the TD is technically feasible by applying NIR imaging systems that are routinely used. The clinical application of this technique requires subsequent validation to prove improvement in rates of chylous fistula and intraoperative recognition of injury with a decrease in subsequent morbidity.
METHODS

Patient Cohort
All the patients for this study were recruited from the surgical oncology clinic at a single institution from May to September of 2017. Patients with an indication for a left lateral neck dissection in conjunction with other procedures were included in the study. Because ICG is contraindicated for minors, breastfeeding patients, and those with allergies to iodine, it was not used for these patients. This study was approved by the institutional review board. The imaging device and the ICG compound are Food and Drug Administration (FDA) approved and used routinely in clinical care.
Surgical Technique and Postoperative Care
A left lateral dissection (LND) was performed, with no deviations in the technical aspects of the procedure for the purposes of this study, by three surgical oncologists (L.A.S., A.M.T., J.E.P.). Dissection in the neck included levels 2, 3, and 4 routinely, with dissection of levels 5 and 6 if indicated. The internal jugular vein, spinal accessory nerve, recurrent laryngeal nerve, and vagus nerve were not resected unless involved with tumor. Approximately 15 min before dissection of level 4, the dorsum of the left foot immediately below the ankle was injected with ICG subcutaneously. Imaging was performed periodically throughout dissection of level 4 as dissection of the subclavian vein and junction with the internal jugular vein was performed. The time from injection of ICG to imaging of the TD was recorded, as well as the total imaging time. After the dissection was completed, with removal of the specimen and the TD identified, final imaging was performed. A surgical drain was used at completion of the operation and placed to bulb suction.
Indocyanine green was reconstituted in standard vials containing 25 mg of powder with 10 mL of sterile saline to a concentration of 2.5 mg/mL. A 25-g insulin type needle and a 5-mL syringe was used for injection subcutaneously. An area of normal skin free from prior injury or infection was identified on the dorsum of the foot. Alcohol was used to clean the skin, and 1-2 mL (2.5-5 mg) of ICG was used for each injection. If the TD was not identified within 30 min after injection, the ICG was re-dosed with another 1-2 mL, and only one re-dosing was used.
After the operation, the patients were admitted to the surgical ward for monitoring. A high-fat diet was started on postoperative day 1 for evaluation of chylous fistula. Drain output was monitored for chyle after a diet was started, and if no evidence of leak was observed, the patient was discharged on postoperative day 2 after removal of the drain.
Imaging Procedures
Images were obtained during surgery at a time determined by the surgeon when identification of the TD was optimal. Fluorescence images were obtained using the PDE-neo 2 imager (Hamamatsu model C10935-400; Hamamatsu Photonics, Hamamatsu City, Japan). The camera of this imager is a handheld device draped in a sterile covering and used to obtain images during the surgery, which are seen on an adjacent monitor. The operating room lights are turned off during imaging. Imaging is performed with the probe held at the patient's head and pointed caudally and medially into the space below the clavicle (Fig. 1) . This provides the optimal angle for imaging into this narrow space. Image collection is realtime, and both video and select images are saved on a USB port within the device.
In this study, imaging during identification of the TD lasted 1-2 min. Final imaging of the TD after completion of the dissection lasted up to 5 min. After the operation, all images were transferred to a protected network drive.
RESULTS
Imaging of the TD was attempted in six patients and performed successfully for five of the patients (83.3%), Table 1 . The indications for surgery included thyroid cancer (medullary, poorly differentiated, and papillary) and melanoma. None of the patients had a history of neck radiation. However, three patients had a history of prior neck surgery. One patient had undergone revision lateral neck dissection for cancer recurrence, and two patients had undergone recent central neck surgery.
Overall, the time from injection to NIR imaging and identification ranged from 15 to 90 min. The time varied significantly among the patients due to trial and error as well as uncertainty about the time required for ICG to travel from the legs to the neck. There was no standard time for the use of NIR imaging, and the area of expected TD location was imaged periodically throughout the dissection. For the patient who required 90 min from injection, the ICG was injected before start of the neck dissection and imaged only after it was completed. For three patients, ICG was re-dosed to assist with identification.
The time to performance of imaging was 5-10 min per patient and was split between multiple imaging sessions. This time was added to the operation by performance of the procedure and included turning off the operating room lights, using the NIR imager, and recording video or taking appropriate pictures. No patients had an identified injury to the TD intraoperatively or a postoperative chyle leak. No surgical complications were related to ICG injection or imaging, and no adverse events occurred with subcutaneous injection of ICG. The TD was identified in the five patients during the dissection around the level of the subclavian vein (SV) at its junction with the internal jugular vein (IJV).
In patient 4, a structure that appeared to be the TD was identified during dissection without the use of NIR imaging. A branch from this structure was clipped as it entered the specimen, with imaging confirming that this was in fact the TD (Fig. 2) . The TD was clearly visualized after completion of the dissection and could be imaged terminating at the junction between the SC and the IJV (Video S1).
In patient 5, the TD was identified by fluorescence NIR imaging alone and further dissected after identification (Fig. 3) . A level 4 lymph node also was weakly fluorescent in this patient. Fluorescent chylous fluid containing bubbles could be seen entering the SV (Video S2). Fluorescence was seen only in the TD and lymph nodes and not in the vascular structures.
In one patient, the TD was not identified due to unknown factors. This patient had undergone resection of a large left thyroid mass at another hospital 1 month before the current operation. In the current operation, he had a sternotomy, resection of a substernal mass with en bloc sternectomy, and resection of the recurrent laryngeal nerve by the thoracic oncologist before performance of the lateral neck dissection. Re-dosing of ICG was performed, and ample time was given for imaging.
DISCUSSION
This report presents the first described application of the ICG and NIR imaging system to identify the TD in the neck during a left lateral neck dissection. This concept originated from management of the first patient in our series with multiple endocrine neoplasia type 2B (MEN2B) undergoing revision bilateral neck dissection for recurrence at level 4. We were concerned about dissection in this area due to scar obliterating the planes and potential injury to the TD because patients with prior neck dissection or radiation have a higher rate of chylous fistula. 6 The technique was adapted from reports of ICG identifying sentinel lymph nodes related to breast, melanoma, and cervical cancer. 9 Ultimately, the technique was successful for this first patient and later confirmed with the subsequent patients, showing an overall identification rate of 83.3%.
Since the 1950 s, ICG has been used to assess blood flow and tissue viability and to identify lymphatic tissues. Its use currently is prevalent in cancer surgery. 9 Multiple NIR These systems primarily use ICG as their imaging fluorophore, which is reimbursable for certain procedures. Lymphangiography using ICG and NIR imaging is commonly used for patients with lymphedema to identify the blocked lymphatic channels for surgical reconstruction. 19 Our described technique is an extension of these concepts and a new application of the existing technology that requires continued refinement. As our experience with NIR imaging grows, the accuracy of our dissection and identification rate likely will improve. In one study, a learning curve of 20 laparoscopic ICG-directed SLN procedures was required to increase accuracy. 20 We are currently performing a clinical trial to optimize and standardize the technique of combining ICGdirected identification of the TD with lateral neck dissection.
Few studies reported in the literature have used ICG to image the TD, and none have investigated the neck. Animal models of this process have included ICG lymphangiography of the TD in the thoracic cavity in rats and pigs. 21 In the current study, we were able to image the TD within 5 min after injection in the lower leg, and the fluorescence activity lasted for 60 min. In previous case reports, the TD had been identified in humans using ICG in the chest and abdomen. After injury to the TD in the chest or abdomen during esophagectomy with resultant chylothorax or chylous ascites, ICG injection in the lower leg resulted in identification of the leak for its successful ligation. 15, 16 The optimal time from injection of ICG to imaging in humans still needs to be determined, although it appears that the florescence signal lasts up to 90 min. Further optimization of the technique will involve early injection of ICG before dissection and then subsequent imaging of the TD area before, during, and after dissection is performed.
Although none of our patients had a TD injury or chylous fistula, the technique may be helpful in identifying TD injury. Currently, no routinely used diagnostics are available for identification or treatment of a chyle leak intraoperatively. A single study using abdominal compression after neck dissection showed unrecognized chyle leak in 6.3% of the patients. 22 Of the 13 patients, 2 had persistent leak after identification and suture ligation of the newly identified fistula and also after surgery.
When high-output chyle leak is recognized postoperatively and fails conservative management, reports have described minimally invasive radiologic procedures using embolization or sclerosing agents. 23 Bipedal lymphangiography using ethiodized oil injected into the lymphatic channels in the dorsum of the foot has been used to identify the abdominal and thoracic portions of the duct as well as leak in the chest. 24 However, the majority of chylous fistulas require open surgical ligation, and this novel application of NIR imaging may be effective in identifying the TD for assistance with fistula closure.
The technique of NIR imaging routinely during neck dissection is limited by several issues common to this technology. Fluorescence penetration through tissues is low, at a maximal depth of 8 mm. 25 Significant dissection is required in the tissue before fluorescence can be seen. In our experience, the anatomy is delineated after dissection, a dynamic process that requires switching to the hand-held imager intermittently during the dissection. The whole process can take time, and in our series added 5-10 min of general anesthesia. Furthermore, the cost can be significant, and although ICG is inexpensive, an investment in the imaging equipment is required. Optimization and standardization of the injection and imaging technique are required before this method can be adopted and used to identify or prevent TD injury.
In conclusion, we present the first application of ICG and NIR imaging for the purpose of identifying the TD in the neck during lateral neck dissection. This technique is feasible, simple to perform, and safe, making it a potential important tool for the surgeon. Given that chyle leaks are the most common complication after a left lateral neck dissection, this technique has the potential to change the current practice of this operation. The utility of the technique will certainly be helpful in identifying the TD in select patients whose dissection is difficult, as in re-operative cases, and in patients with prior neck radiation or trauma to the area. It also will have utility for identifying the site of injury when chylous fluid is identified in the wound intraoperatively and for confirming that repair is complete. Further work is required to optimize the procedure so it can be incorporated easily into routine practice. 
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